(Q46032053)

18 December 2017

title

Metabolic links between diabetes and Alzheimer's disease. (English)

1 reference

18 December 2017

0 references

Pamela A Maher

1

1 reference

18 December 2017

David R Schubert

series ordinal

2

1 reference

18 December 2017

publication date

1 May 2009

1 reference

18 December 2017

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

18 December 2017

volume

9

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

617-630

1 reference

18 December 2017

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

cites work

1 reference

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?

21 January 2018

1 reference

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

21 January 2018

1 reference

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

Development of dementing illnesses in an 80-year-old volunteer cohort

21 January 2018

1 reference

Predictors of cognitive impairment and dementia in older people with diabetes.

21 January 2018

1 reference

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

21 January 2018

1 reference

The effect of borderline diabetes on the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

Hyperinsulinemia and risk of Alzheimer disease.

21 January 2018

1 reference

Hyperinsulinemia and cognitive decline in a middle-aged cohort.

21 January 2018

1 reference

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

21 January 2018

1 reference

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

Impaired insulin secretion increases the risk of Alzheimer disease

21 January 2018

1 reference

Regulation of insulin receptor function

21 January 2018

1 reference

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

Molecular connexions between dementia and diabetes.

21 January 2018

1 reference

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

21 January 2018

1 reference

Mitogen-activated protein kinases in synaptic plasticity and memory.

21 January 2018

1 reference

Targeting the CREB pathway for memory enhancers

21 January 2018

1 reference

21 January 2018

The many faces of CREB

1 reference

Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat.

21 January 2018

1 reference

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

Beta-amyloid deposition in brains of subjects with diabetes

21 January 2018

1 reference

21 January 2018

1 reference

Restraining PI3K: mTOR signalling goes back to the membrane.

21 January 2018

1 reference

Scaffolding function of PAK in the PDK1-Akt pathway

21 January 2018

1 reference

Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.

21 January 2018

1 reference

Role for neuronal insulin resistance in neurodegenerative diseases

21 January 2018

1 reference

A biochemical and functional characterization of diet-induced brain insulin resistance

21 January 2018

1 reference

Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats.

21 January 2018

1 reference

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

'Lipoproteins, glycoxidation and diabetic angiopathy'.

21 January 2018

1 reference

21 January 2018

The metabolic syndrome

1 reference

Role of arachidonic acid and other free fatty acids in mitochondrial dysfunction in brain ischemia

21 January 2018

1 reference

In VitroInhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters

21 January 2018

1 reference

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

21 January 2018

1 reference

Oxidative regulation of fatty acid-induced tau polymerization.

21 January 2018

1 reference

Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation

21 January 2018

1 reference

Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease

21 January 2018

1 reference

5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

21 January 2018

1 reference

Modulation of the arachidonic cascade with omega3 fatty acids or analogues: potential therapeutic benefits

21 January 2018

1 reference

Modification of glutamate receptors by phospholipase A2: its role in adaptive neural plasticity

21 January 2018

1 reference

Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling

21 January 2018

1 reference

Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway

21 January 2018

1 reference

Arachidonic acid metabolites contribute to the irreversible depolarization induced by in vitro ischemia

21 January 2018

1 reference

Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid

21 January 2018

1 reference

Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction.

21 January 2018

1 reference

beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.

21 January 2018

1 reference

The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide

21 January 2018

1 reference

Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases

21 January 2018

1 reference

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases

21 January 2018

1 reference

The regulation of reactive oxygen species production during programmed cell death

21 January 2018

1 reference

Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease

21 January 2018

1 reference

Regional membrane phospholipid alterations in Alzheimer's disease.

21 January 2018

1 reference

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

21 January 2018

1 reference

Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).

21 January 2018

1 reference

Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells

21 January 2018

1 reference

Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

21 January 2018

1 reference

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease

21 January 2018

1 reference

Role for glyoxalase I in Alzheimer's disease.

21 January 2018

1 reference

Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells

21 January 2018

1 reference

On the mechanisms of ageing suppression by dietary restriction-is persistent glycolysis the problem?

21 January 2018

1 reference

Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans

21 January 2018

1 reference

Glucose metabolism and Alzheimer's disease

21 January 2018

1 reference

The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide

21 January 2018

1 reference

Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms

21 January 2018

1 reference

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

21 January 2018

1 reference

Hyperglycemic pseudohypoxia and diabetic complications.

21 January 2018

1 reference

Anti-AGEing defences against Alzheimer's disease

21 January 2018

1 reference

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

21 January 2018

1 reference

Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease

21 January 2018

1 reference

Alzheimer-like changes in rat models of spontaneous diabetes.

21 January 2018

1 reference

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

Capillary number and percentage closed in human diabetic sural nerve

21 January 2018

1 reference

Diabetes, cognitive function, and the blood-brain barrier

21 January 2018

1 reference

Neurodegenerative disorders associated with diabetes mellitus

21 January 2018

1 reference

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

21 January 2018

1 reference

Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease

21 January 2018

1 reference

Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin.

21 January 2018

1 reference

Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy

21 January 2018

1 reference

Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3.

21 January 2018

1 reference

Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease

21 January 2018

1 reference

Role of astrocytes in cerebrovascular regulation

21 January 2018

1 reference

Neurovascular coupling and cerebral autoregulation can be described in terms of a control system.

21 January 2018

1 reference

A short history of beverages and how our body treats them.

21 January 2018

1 reference

Polyol pathway and diabetic peripheral neuropathy

21 January 2018

1 reference

In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

21 January 2018

1 reference

Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines

21 January 2018

1 reference

Methylglyoxal: its presence in beverages and potential scavengers

21 January 2018

1 reference

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

21 January 2018

1 reference

Advanced glycation in health and disease: role of the modern environment

21 January 2018

1 reference

Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies

21 January 2018

1 reference

Alcohol at Moderate Levels Decreases Fibrinogen Expression In Vivo and In Vitro

21 January 2018

1 reference

Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo

21 January 2018

1 reference

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

21 January 2018

1 reference

Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory

21 January 2018

1 reference

Epidemiological studies of exercise in diabetes prevention

21 January 2018

1 reference

Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

21 January 2018

1 reference

A broadly neuroprotective derivative of curcumin

21 January 2018

1 reference

Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes

21 January 2018

1 reference

Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts

21 January 2018

1 reference

Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein

21 January 2018

1 reference

Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.09.18

1 reference

18 December 2017

PubMed ID

19402773

1 reference

18 December 2017